Abbott Laboratories (ABT) News Today $129.54 -2.09 (-1.59%) As of 10:13 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Huntington National Bank Increases Stock Holdings in Abbott Laboratories (NYSE:ABT)Huntington National Bank boosted its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 1.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 444,258 shares of the healthcare product maker's stock afterApril 4 at 6:51 AM | marketbeat.comAbbott Laboratories (NYSE:ABT) Shares Sold by Massachusetts Financial Services Co. MAMassachusetts Financial Services Co. MA lessened its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 3.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,811,351 sharesApril 3 at 6:34 AM | marketbeat.comRFG Bristol Wealth Advisors LLC Takes Position in Abbott Laboratories (NYSE:ABT)RFG Bristol Wealth Advisors LLC bought a new stake in Abbott Laboratories (NYSE:ABT - Free Report) in the 4th quarter, according to its most recent 13F filing with the SEC. The firm bought 3,478 shares of the healthcare product maker's stock, valued at approximately $393,000. Other hedge funds andApril 3 at 6:33 AM | marketbeat.comScholtz & Company LLC Boosts Holdings in Abbott Laboratories (NYSE:ABT)Scholtz & Company LLC boosted its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 14.2% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 47,461 shares of the healthcare product maker's stock after purchasing an additional 5,902 shares durinApril 3 at 6:17 AM | marketbeat.comAbbott Laboratories (NYSE:ABT) Shares Sold by Groupama Asset ManagmentGroupama Asset Managment cut its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 66.5% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 76,578 shares of the healthcare product maker's stock after selling 151,870 shares during theApril 3 at 6:16 AM | marketbeat.comDiametric Capital LP Purchases Shares of 2,021 Abbott Laboratories (NYSE:ABT)Diametric Capital LP acquired a new position in shares of Abbott Laboratories (NYSE:ABT - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 2,021 shares of the healthcare product maker's stock, valued at approApril 3 at 5:54 AM | marketbeat.comAbbott Laboratories (NYSE:ABT) Shares Acquired by StoneX Group Inc.StoneX Group Inc. boosted its position in Abbott Laboratories (NYSE:ABT - Free Report) by 56.8% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 20,246 shares of the healthcare product maker's stock after purchasing an additional 7,April 3 at 5:46 AM | marketbeat.comNational Bank of Canada FI Lowers Holdings in Abbott Laboratories (NYSE:ABT)National Bank of Canada FI cut its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 7.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 960,953 shares of the healthcare product maker'April 3 at 5:36 AM | marketbeat.comThe Zacks Analyst Blog Highlights McDonald's, Abbott Laboratories, O'Reilly Automotive and MIND TechnologyApril 3 at 12:17 AM | uk.finance.yahoo.comPotomac Fund Management Inc. ADV Invests $1.86 Million in Abbott Laboratories (NYSE:ABT)Potomac Fund Management Inc. ADV purchased a new stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 16,399 shares of the healthcare product maker's stock, vaApril 2 at 7:07 AM | marketbeat.comTrexquant Investment LP Purchases 88,531 Shares of Abbott Laboratories (NYSE:ABT)Trexquant Investment LP raised its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 28.1% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 403,618 shares of the healthcare product maker's stApril 2 at 6:46 AM | marketbeat.com3,186 Shares in Abbott Laboratories (NYSE:ABT) Bought by May Hill Capital LLCMay Hill Capital LLC purchased a new stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 3,186 shares of the healthcare product maker's stock, valued at approximately $360,000.April 2 at 6:46 AM | marketbeat.comGeode Capital Management LLC Raises Position in Abbott Laboratories (NYSE:ABT)Geode Capital Management LLC raised its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 2.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 35,668,834 shares of the heaApril 2 at 6:20 AM | marketbeat.comAlliancebernstein L.P. Trims Stock Holdings in Abbott Laboratories (NYSE:ABT)Alliancebernstein L.P. reduced its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 7.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,844,598 shares of the healthcare productApril 2 at 5:33 AM | marketbeat.comAbbott Laboratories (NYSE:ABT) Receives $137.94 Average Price Target from AnalystsApril 2 at 1:51 AM | americanbankingnews.comAbbott joins AFib-treating race with tech that may skip general anesthesiaApril 1 at 11:43 PM | msn.comAbbott Laboratories (NYSE:ABT) Shows Promising Results in Heart Valve Device StudyApril 1 at 11:43 PM | finance.yahoo.comAbbott Laboratories (ABT)'s Winning Formula: Financial Metrics and Competitive StrengthsApril 1 at 1:27 PM | gurufocus.comAbbott Laboratories (NYSE:ABT) Stock Position Boosted by HighPoint Advisor Group LLCHighPoint Advisor Group LLC increased its position in Abbott Laboratories (NYSE:ABT - Free Report) by 2.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 165,957 shares of the healthcare product maker's sApril 1 at 7:19 AM | marketbeat.comAbbott Laboratories (NYSE:ABT) Shares Acquired by Franklin Resources Inc.Franklin Resources Inc. raised its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 10.6% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 10,794,632 shares of the healthcare product maker's stock after purchasing an additional 1,030,57April 1 at 7:10 AM | marketbeat.comB. Metzler seel. Sohn & Co. AG Raises Stock Holdings in Abbott Laboratories (NYSE:ABT)B. Metzler seel. Sohn & Co. AG boosted its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 304.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 914,635 shares of the healthcare pApril 1 at 6:57 AM | marketbeat.comAbbott Laboratories (NYSE:ABT) Shares Sold by Cannell & Spears LLCCannell & Spears LLC cut its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 2.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 577,540 shares of the healthcare product maker's stock afterApril 1 at 6:40 AM | marketbeat.comSummit Financial LLC Acquires 8,986 Shares of Abbott Laboratories (NYSE:ABT)Summit Financial LLC grew its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 18.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 58,939 shares of the healthcare product maker's stoApril 1 at 6:39 AM | marketbeat.comAIA Group Ltd Buys 10,701 Shares of Abbott Laboratories (NYSE:ABT)AIA Group Ltd lifted its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 24.0% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 55,307 shares of the healthcare product maker's stock after acquiring an additional 10,701 shareApril 1 at 6:01 AM | marketbeat.comWellington Management Group LLP Grows Stock Holdings in Abbott Laboratories (NYSE:ABT)Wellington Management Group LLP lifted its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 2.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 26,392,302 shares of the healthcare prApril 1 at 5:53 AM | marketbeat.comPartners in Financial Planning Takes $259,000 Position in Abbott Laboratories (NYSE:ABT)Partners in Financial Planning acquired a new position in shares of Abbott Laboratories (NYSE:ABT - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 2,288 shares of the healthcApril 1 at 5:51 AM | marketbeat.comAbbott Laboratories (NYSE:ABT) Holdings Raised by O Shaughnessy Asset Management LLCO Shaughnessy Asset Management LLC grew its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 23.7% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 198,839 shares of the healApril 1 at 5:43 AM | marketbeat.comSchroder Investment Management Group Raises Position in Abbott Laboratories (NYSE:ABT)Schroder Investment Management Group increased its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 8.1% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 1,079,490 shares of the healthcare product maker's stock after acquiApril 1 at 5:16 AM | marketbeat.comAbbott reports data from Triluminate trial evaluating TriClipMarch 31, 2025 | markets.businessinsider.comNew Late-Breaking Data Reinforce Benefits of Abbott's TriClip™ for People With Leaky Tricuspid Heart ValveMarch 31, 2025 | prnewswire.comCIBC Private Wealth Group LLC Sells 119,519 Shares of Abbott Laboratories (NYSE:ABT)CIBC Private Wealth Group LLC reduced its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 2.5% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 4,667,557 shares of the healthcare product maker's stock after selling 119,519 shares during thMarch 31, 2025 | marketbeat.comAbbott Laboratories (NYSE:ABT) Shares Sold by Mawer Investment Management Ltd.Mawer Investment Management Ltd. trimmed its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 3.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,356,107 shares of the healthcare product maker's stockMarch 31, 2025 | marketbeat.comCalifornia Public Employees Retirement System Sells 120,107 Shares of Abbott Laboratories (NYSE:ABT)California Public Employees Retirement System lessened its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 3.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,796,537 shares ofMarch 31, 2025 | marketbeat.comAbbott Laboratories (NYSE:ABT) Shares Acquired by RWA Wealth Partners LLCRWA Wealth Partners LLC boosted its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 1.9% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 254,544 shares of the healthcare product maker's stock after acquiring an additionalMarch 31, 2025 | marketbeat.comStrategy Asset Managers LLC Sells 5,524 Shares of Abbott Laboratories (NYSE:ABT)Strategy Asset Managers LLC lowered its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 58.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 3,868 shares of the healthcare product maker's stock afterMarch 31, 2025 | marketbeat.comLevel Four Advisory Services LLC Lowers Stake in Abbott Laboratories (NYSE:ABT)Level Four Advisory Services LLC lessened its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 19.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 19,742 shares of the healthcare product maker's stock after sellMarch 31, 2025 | marketbeat.comPictet Asset Management Holding SA Lowers Stock Position in Abbott Laboratories (NYSE:ABT)Pictet Asset Management Holding SA lowered its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 4.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 766,211 shares of the healthcare prodMarch 31, 2025 | marketbeat.comTD Cowen Reaffirms Their Buy Rating on Abbott Laboratories (ABT)March 30, 2025 | markets.businessinsider.comAllianz SE Invests $8.34 Million in Abbott Laboratories (NYSE:ABT)Allianz SE bought a new position in Abbott Laboratories (NYSE:ABT - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 73,949 shares of the healthcare product maker's stock, valued at approximateMarch 30, 2025 | marketbeat.comAbbott Laboratories (NYSE:ABT) Shares Sold by Mitchell Sinkler & Starr PAMitchell Sinkler & Starr PA reduced its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 12.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 98,783 shares of the healthcare product mMarch 30, 2025 | marketbeat.com52,096 Shares in Abbott Laboratories (NYSE:ABT) Bought by Allstate CorpAllstate Corp purchased a new stake in Abbott Laboratories (NYSE:ABT - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 52,096 shares of the healthcare product maker's stock, valued at approximately $5,893,000. Several oMarch 30, 2025 | marketbeat.comBrown Brothers Harriman & Co. Sells 58,222 Shares of Abbott Laboratories (NYSE:ABT)Brown Brothers Harriman & Co. trimmed its position in Abbott Laboratories (NYSE:ABT - Free Report) by 2.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,289,091 shares of the healthcare product makeMarch 30, 2025 | marketbeat.comAbbott Laboratories (NYSE:ABT) Given Average Recommendation of "Moderate Buy" by AnalystsAbbott Laboratories (NYSE:ABT - Get Free Report) has been assigned an average rating of "Moderate Buy" from the nineteen research firms that are covering the firm, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold recommendation, fourteen have issued a buy reMarch 30, 2025 | marketbeat.comAbbott Laboratories (ABT) Offers Stability with Diverse Revenue StreamsMarch 29, 2025 | gurufocus.comAbbott Laboratories (NYSE:ABT) Shares Bought by DnB Asset Management ASDnB Asset Management AS increased its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 3.5% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 573,570 shares of the healthcare product maker's stock after acquiring an additional 19,226 shares duMarch 29, 2025 | marketbeat.comdenkapparat Operations GmbH Invests $347,000 in Abbott Laboratories (NYSE:ABT)denkapparat Operations GmbH purchased a new position in shares of Abbott Laboratories (NYSE:ABT - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 3,070 shares of the healthcare product maker's stock, valued at approximately $347,000. OthMarch 29, 2025 | marketbeat.comOrion Portfolio Solutions LLC Sells 4,765 Shares of Abbott Laboratories (NYSE:ABT)Orion Portfolio Solutions LLC lowered its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 2.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 183,932 shares of the healthcare product maker's stock after selling 4,765 sharMarch 29, 2025 | marketbeat.com3 Relatively Safe Stocks to Buy Right NowMarch 29, 2025 | fool.comNomura Asset Management Co. Ltd. Raises Stock Holdings in Abbott Laboratories (NYSE:ABT)Nomura Asset Management Co. Ltd. raised its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 1.0% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,119,777 shares of the healthcare product maker's stock after acquiMarch 29, 2025 | marketbeat.comMay 9th Options Now Available For Abbott Laboratories (ABT)March 29, 2025 | nasdaq.com Remove Ads Get Abbott Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for ABT and its competitors with MarketBeat's FREE daily newsletter. Email Address ABT Media Mentions By Week ABT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ABT News Sentiment▼1.320.61▲Average Medical News Sentiment ABT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ABT Articles This Week▼6528▲ABT Articles Average Week Remove Ads Get Abbott Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for ABT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ISRG News BSX News SYK News MDT News BDX News EW News IDXX News RMD News DXCM News STE News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:ABT) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abbott Laboratories Please log in to your account or sign up in order to add this asset to your watchlist. Share Abbott Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.